| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/29/1997 | WO1997018708A1 Broad spectrum antibiotic peptide |
| 05/29/1997 | WO1997015288A3 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/29/1997 | WO1997013500A3 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 05/29/1997 | WO1997009343A3 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
| 05/29/1997 | WO1997006247A3 Deubiquitinating enzymes that regulate cell growth |
| 05/29/1997 | WO1997004748A3 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 05/29/1997 | WO1996036713A3 Eck receptor ligands |
| 05/29/1997 | CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2249343A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | CA2238610A1 Fine tuned protegrins |
| 05/29/1997 | CA2238429A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | CA2238404A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions |
| 05/29/1997 | CA2238290A1 Methods for determining compounds capable of inhibiting the activities of the ha-ras oncogene |
| 05/29/1997 | CA2238176A1 Tumour vaccine and process for the preparation thereof |
| 05/29/1997 | CA2238167A1 Method of treating sepsis |
| 05/29/1997 | CA2238075A1 Protein which interacts with the huntington's disease gene product, cdna coding therefor, and antibodies thereto |
| 05/29/1997 | CA2238028A1 Combinational therapeutic methods employing nitric oxide scavengers |
| 05/29/1997 | CA2238018A1 Method of treating involuntary muscle dysfunction with relaxin hormone |
| 05/29/1997 | CA2238010A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | CA2236825A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
| 05/29/1997 | CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/29/1997 | CA2210622A1 An agent protecting endothelial cells |
| 05/28/1997 | EP0775750A2 Preparation of proteins from pro-proteins by fusion proteins derived from furin or furinanalogs |
| 05/28/1997 | EP0775746A2 Coccidiosis poultry vaccine |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775711A1 Peptide having antithrombotic activity and process for producing the same |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775207A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 05/28/1997 | EP0775206A1 Dual hybrid system |
| 05/28/1997 | EP0775205A1 Novel cell surface receptor, antibody compositions, and methods of using same |
| 05/28/1997 | EP0775204A1 Antitumor antisense oligonucleotides |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775200A1 Recombinant kat enzyme and process for its preparation |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775197A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 05/28/1997 | EP0775160A1 Cyclic hexapeptide somatostatin analogues |
| 05/28/1997 | EP0775159A1 Novel process for the production of biologically active dimeric protein |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775157A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 05/28/1997 | EP0775153A1 Nucleic acid to initiate the activity of ribonuclease h or reverse transcriptase |
| 05/28/1997 | EP0775110A1 Arylthio compounds as antibacterial and antiviral agents |
| 05/28/1997 | EP0774973A1 Treatment of cancer with human chorionic gonadotropin |
| 05/28/1997 | EP0774972A1 The use of des-aspartate-angiotensin i as an anti-cardiac hypertrophic agent |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0774964A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 05/28/1997 | EP0688336B1 Peptide boronic acid derivatives having protease inhibiting activity |
| 05/28/1997 | EP0687273B1 Collagenase activity inhibitor and cosmetic composition containing same |
| 05/28/1997 | EP0679097B1 Tgf-beta formulation for inducing bone growth |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | EP0526511B1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | DE19543628A1 Humanes, im Blut zirkulierendes Peptid mit insulinotroper Wirkung (GCAP-II-(89-112), (Guanylyl Cyclase C Aktivierendes Peptid II) und seine GCAP-Analoga, insbesondere das GCAP-I-(99-115), seine Anwendung als pharmakologischer Wirkstoff und Benutzung seines Wirkungsprinzipes zur Bereitstellung neuer GC-C-abhängiger insulinotroper Wirkstoffe Human, circulating in the blood insulinotropic peptide effect (GCAP-II (89-112), (guanylyl cyclase-activating peptide C II) and its GCAP analogues, in particular the GCAP-I (99-115), its use as a pharmacological drug use and its effect principle to provide new GC-C-dependent insulinotropic drugs |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150820A Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 05/28/1997 | CN1150805A Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150760A Methods for inducing T cell tolerance to tissue or organ graft |
| 05/28/1997 | CN1150759A Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents |
| 05/28/1997 | CN1150756A Stable protein: phospholipid composition and method |
| 05/28/1997 | CN1150754A Human osteoclast-derived cathepsin |
| 05/28/1997 | CN1150602A Human thymosin alpha-source and preparing method thereof |
| 05/28/1997 | CN1150601A Bacteriocin |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/27/1997 | US5633442 Method of producing pathogen-resistant plants |
| 05/27/1997 | US5633395 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/27/1997 | US5633350 Method for the isolation and purification of vitamin K-dependent proteins |
| 05/27/1997 | US5633347 Treatment of small-cell lung carcinomas |
| 05/27/1997 | US5633346 Cyclization, fungicides |
| 05/27/1997 | US5633345 Cyclic peptides |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633277 Antiinflammatory |
| 05/27/1997 | US5633270 Thiazolidine derivatives, preparation thereof and drugs containing samem |
| 05/27/1997 | US5633263 Linear somatostatin analogs |
| 05/27/1997 | US5633232 Tachykinin antagonist dipeptides |
| 05/27/1997 | US5633231 Cytomegalovirus |
| 05/27/1997 | US5633230 Using an arginine containing oligopeptides |
| 05/27/1997 | US5633228 Prevention and treatment of peripheral neuropathy |
| 05/27/1997 | US5633227 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 05/27/1997 | US5633226 Water in oil emulsion with water solubility active ingredient, triglyceride or diester of propylene glycol, surfactant and additive capable of converting mixture to oil in water emulsion by addition of water |
| 05/27/1997 | US5633161 Murine gene fomy030 coding for tumor progression inhibitor |
| 05/27/1997 | US5633158 Culture product; genetic engineering |
| 05/27/1997 | US5633150 Preparation of functional human factor VIII |
| 05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
| 05/27/1997 | US5633147 Transforming growth factor αH1 |
| 05/27/1997 | US5633145 TNFα receptor-derived binding protein |
| 05/27/1997 | US5633141 Assaying platelet factor 4 neutrophil agonists |
| 05/27/1997 | US5633136 ALL-1 polynucleotides for leukemia detection and treatment |
| 05/27/1997 | US5633135 Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities |
| 05/27/1997 | US5633130 Zwitterionic buffer |
| 05/27/1997 | US5632994 Fas associated proteins |
| 05/27/1997 | US5632993 Immunogens and the use thereof for obtaining antibodies against HbA1c |
| 05/27/1997 | US5632991 Antibodies specific for E-selectin and the uses thereof |
| 05/27/1997 | US5632990 Linked to carboxypeptidase or nitroreductase; anticarcinogenic agents |
| 05/27/1997 | US5632989 Screening with a monoclonal antibodies |
| 05/27/1997 | US5632988 Containing the specific amino acid sequence arg-arg-lys-trp-gln in their structure |
| 05/27/1997 | US5632986 Annexin-urokinase |